Кориол

Quick links to important sections

Кориол

Selected form

Method of action: Antihypertensive

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Кориол

What is Кориол? (Carvedilol)

Property Description
Active ingredient Carvedilol
Form Oral tablets (solid)
Pharmacological class alpha-/beta-Adrenergic Antagonist
General purpose Reducing cardiac workload and lowering blood pressure
Origin Synthetic
Composition Single active ingredient (racemic mixture)

Кориол: A Dual-Action Cardiovascular Agent

Кориол is a synthetic pharmaceutical product featuring the single active ingredient, Carvedilol, designated as an antihypertensive agent intended for managing chronic cardiovascular strain. Pharmacologically, it is primarily categorized as an alpha-/beta-adrenergic blocking agent due to its simultaneous actions as a non-selective beta-adrenergic antagonist and an alpha1-adrenergic antagonist. This dual mechanism is utilized for the management of the cardiovascular system. This unique combination establishes its use in scenarios where both reduction in cardiac activity and peripheral vasodilation are therapeutically required.

Composition and Form: The Structure of Carvedilol

The medication is formulated for the oral route of administration and is supplied as a solid pharmaceutical preparation, specifically in the form of tablets. The active substance, Carvedilol, is a lipophilic drug chemically composed as a racemic mixture of its R(+) and S(-) enantiomers. The S(-) enantiomer primarily mediates the beta-blocking activity, while both forms contribute to the alpha-blocking action. This sophisticated chemical composition is a key differentiator from simpler beta-blockers, contributing to its multi-faceted therapeutic profile.

The General Purpose of Кориол

The therapeutic utility of the drug is based on its integrated physiological action, which consistently reduces the force of heart contractions while promoting the widening (vasodilation) of peripheral blood vessels. Its action includes mitigating the effects of chronic neurohormonal overstimulation within the vasculature. This outcome translates directly into the lowering of high blood pressure and a measurable reduction in the chronic workload on the heart.

What side effects are possible with Кориол?

Possible Side Effects and Safety Information

The safety profile for Carvedilol (Кориол) is defined by officially documented adverse reactions, classified by frequency and grouped by the body system affected, according to regulatory standards (e.g., FDA, EMA). This information establishes the formal risk framework for the medicine.


Frequency-Classified Adverse Reactions

The most frequently reported effects, categorized as Very Common ( ge 10% in heart failure patients) or Common ( ge 1%), include:

  • General and Cardiovascular: Dizziness, Fatigue, Hypotension (low blood pressure), Bradycardia (slow heart rate), and Edema (fluid retention) or worsening heart failure.
  • Metabolic and Gastrointestinal: Hyperglycemia (high blood sugar, especially in diabetics), Nausea, and Diarrhea.

Less common effects, classified as Uncommon or Rare, include syncope (fainting), certain skin reactions, and changes to vision.


Serious Safety Considerations

Official labeling includes warnings for several serious risks. These include the potential for Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS). Abrupt cessation of the medication is specifically warned against due to the risk of exacerbating existing Coronary Artery Disease (a withdrawal phenomenon).


Population and Context-Specific Safety Notes

The medicine is contraindicated (should not be used) in conditions such as severe hepatic impairment, uncontrolled bronchial asthma, cardiogenic shock, and specific types of severe heart block. Specific cautions are documented for certain patient groups, including:

  • Diabetic Patients: Carvedilol may mask the symptoms of hypoglycemia (low blood sugar), such as a fast heartbeat.
  • Surgical Patients: There is a documented risk of Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Кориол (Carvedilol) overdose focuses on severe depression of the cardiovascular and central nervous systems, requiring immediate emergency intervention as documented in prescribing information.


Documented Overdose Manifestations

Regulatory documents list critical manifestations including profound bradycardia (slow heart rate) and severe hypotension (low blood pressure), which may progress to cardiac insufficiency and life-threatening events such as cardiogenic shock or cardiac arrest. Other documented signs include significant respiratory issues like bronchospasms, and central nervous system effects such as generalized seizures, fainting (syncope), and lapses of consciousness.

Required Emergency Actions

Due to the potential for severe, life-threatening outcomes, immediate medical attention is required in all suspected overdose cases. Regulators mandate that emergency services or the Poison Control center be contacted right away. Urgent intervention is specifically required if an individual has collapsed, experienced a seizure, or has severe difficulty breathing. The documented management plan involves standard supportive treatment, including the use of specific pharmacologic agents like Atropine and Glucagon to address severe effects, with treatment continued consistent with the drug's prolonged half-life.

Therapeutic Uses of Кориол

The therapeutic utility of Кориол (Carvedilol) centers on the long-term management of major chronic cardiovascular diseases, applying to conditions marked by increased physiological stress. This medication is commonly used across therapeutic domains where additional symptomatic support is needed to address significant patient risk.


The drug is relevant for managing conditions characterized by periods of heightened symptoms, including chronic heart failure with reduced ejection fraction, essential hypertension (high blood pressure), and the aftermath of a myocardial infarction in clinically stable patients who have left ventricular dysfunction.

“This medication is commonly used to help with symptoms related to systemic imbalance and heightened physiological activity, assisting with maintaining stability when symptoms become more noticeable.”

Chronic Conditions and Patient Support

Кориол is applied in clinical settings that involve acute or unstable symptom patterns, such as the progression of heart failure. The primary benefit supports general well-being and is relevant for managing the potential for hospitalization associated with worsening symptoms. For patients with hypertension, one of the benefits is the sustained management of blood pressure, which supports general well-being and assists with maintaining functional stability. It is also relevant for easing symptoms related to chronic stable angina pectoris (chest discomfort), which is used for managing symptoms that interfere with daily functioning.


Quick Fact: Relief for Chronic Cardiovascular Strain

This therapy is relevant for easing symptom clusters that create noticeable physiological strain, and it is used when symptomatic management is appropriate for conditions involving recurrent or episodic manifestations like angina or severe hypertension.

Regulatory References

  1. NIH DailyMed official drug labeling

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Corriol (Bepridil)

Corriol is associated with severe regulatory restrictions primarily due to the risk of serious ventricular arrhythmias. Official regulatory documents define strict eligibility criteria.

Contraindications: Must Not Be Used

Use is absolutely contraindicated in populations with conditions that increase the risk of serious cardiac rhythm problems, including:

  • A pre-existing prolonged QT interval (e.g., greater than 0.44 seconds).

  • A history of serious ventricular arrhythmias (such as Torsades de pointes).

  • Use of other medications known to prolong the QT interval.

  • Electrolyte imbalances, specifically uncorrected hypokalemia (low potassium) or hypomagnesemia.

  • Certain severe heart conditions, including uncompensated cardiac insufficiency, severe left ventricular dysfunction, and sick sinus syndrome (without a pacemaker).

Restricted and Conditional Use

Corriol is not recommended for patients who have had a myocardial infarction within the prior three months. Its use is typically restricted to adults with chronic stable angina who have failed to respond to, or are intolerant of, other anti-anginal medications. Patients with hepatic or renal impairment may require special monitoring and dose adjustments. Safety and efficacy have not been established for the pediatric population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pharmacokinetic and Exposure Modifications

The medicine's plasma concentrations are influenced by drugs that interact with the CYP2D6 and CYP2C9 metabolic pathways. Co-administration with enzyme inhibitors, such as Amiodarone, is documented to increase levels of the active S(-) enantiomer by at least two-fold. Conversely, the enzyme inducer Rifampicin can dramatically decrease Carvedilol exposure by approximately 70%. Carvedidlol is also documented to inhibit P-glycoprotein, which results in elevated concentrations of co-administered medicines, notably Digoxin (documented 14% to 16% increase in AUC) and Cyclosporine.

Pharmacodynamic and Procedural Constraints

Additive physiological effects are documented when Carvedilol is combined with other agents that reduce heart rate or blood pressure. This includes Digitalis glycosides and Calcium Channel Blockers (Verapamil or Diltiazem type), increasing the risk of bradycardia and conduction disturbance. The blood-sugar-reducing action of Insulin and oral hypoglycemics may be enhanced. Specific administration rules include advising against the intravenous co-administration of Carvedilol with certain antiarrhythmics. If co-treatment with Clonidine is terminated, the beta-blocker must be gradually discontinued first. The medicine is formally contraindicated in patients with severe hepatic impairment due to substantially reduced clearance.

Mechanism of Action

Кориол (Carvedilol) functions as a non-selective beta-adrenergic receptor antagonist and an alpha1-adrenergic receptor antagonist.

Its S(-) enantiomer provides the non-selective beta-adrenergic receptor blockade, binding to beta1 and beta2 receptors, primarily within the cardiac tissue and vasculature. This competitive antagonism inhibits the Gs-protein-coupled signaling cascade triggered by endogenous catecholamines, such as norepinephrine. The resulting intracellular effect in the myocardium is a reduction in adenylate cyclase activity and a decrease in the subsequent cyclic AMP (cAMP) production. This dampens the protein kinase A (PKA) signaling pathway, leading to a decrease in L-type calcium channel current and reduced cardiac myocyte contractility and rate of spontaneous depolarization.

Both the R(+) and S(-) enantiomers contribute to the alpha1-adrenergic receptor antagonism, primarily in the peripheral vasculature. By blocking alpha1 receptors, the drug inhibits the binding of norepinephrine, which normally mediates vascular smooth muscle cell contraction through an increase in intracellular calcium. The resulting action is peripheral vasodilation and a reduction in total peripheral resistance.

Downstream physiological consequences include a net decrease in cardiac output due to reduced heart rate and contractility, alongside a decrease in systemic vascular resistance.

Dosage and Administration Information

Official Administration Guidelines for Кориол (Carvedilol)

Кориол, the immediate-release form of Carvedilol, is prescribed based on specific administration protocols. The medication is formulated as an oral tablet and is taken twice daily for all primary uses.

Procedural and Dosing Principles

Usage Parameter Administration Principle
Route and Frequency Oral administration; regimen is twice daily.
Timing with Food Tablets must be taken with food to modulate absorption and reduce the risk of orthostatic effects.
Dose Titration Treatment begins at the lowest dose (e.g., 3.125 mg twice daily for Chronic Heart Failure). The dose is then gradually doubled at intervals of at least two weeks until the target maintenance dose is reached.
Dosage Strengths Available strengths include tablets of 3.125 mg, 6.25 mg, 12.5 mg, and 25 mg. Tablets may be divided to achieve the required dose.
Discontinuation Therapy must not be stopped abruptly. The dose must be reduced slowly over one to two weeks if discontinuation is required.

This protocol defines the medication's use as a long-term management approach built upon a process of slow dose escalation to ensure patient stability throughout therapy. The twice-daily frequency and the requirement for co-administration with food are central to the administration procedure. If a dose is missed, it should be skipped, and the next dose should be taken at the regularly scheduled time.

Recent Clinical Evidence

Кориол: Recent Clinical Evidence

Research evidence for this compound is primarily derived from large-scale, multi-center randomized clinical trials (RCTs) across its main indications: chronic heart failure, high blood pressure, and left ventricular dysfunction following a heart attack.

Core Efficacy Research

For chronic heart failure, pivotal RCTs compared the compound against a placebo in patients with reduced heart function. Studies tracked critical outcomes, including all-cause mortality and hospitalizations. Findings consistently reported that the frequency of all-cause mortality was observed to be lower in the patient group receiving the compound over the study period. Research also noted patterns where the frequency of hospitalization for heart failure events was observed to be lower.

Similarly, in studies involving patients with left ventricular dysfunction after a heart attack, research examined outcomes related to death and non-fatal recurrent heart attacks. The primary trials reported a reduced incidence of death in the treated cohort compared to the placebo group within the follow-up period.

For high blood pressure, controlled trials examined changes in clinic and 24-hour ambulatory blood pressure (BP). Studies reported measurable reductions in BP compared to placebo, and consistently described patterns where a lower heart rate was observed.

Evidence Gaps and Uncertainty

Despite the existence of large trials, long-term observational data extending beyond the main study periods are not fully established for all outcomes. Evidence is limited regarding the compound's use in patients with severe co-morbidities like advanced kidney impairment. Furthermore, for the hypertension indication, comparative evidence is lacking regarding the long-term outcomes linked to major cardiovascular events when compared to other classes of antihypertensive medications.

Key Studies & References

  1. The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
  2. Chronic heart failure in adults: diagnosis and management (NICE Guideline NG106)
  3. The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure (NCT00004854)

Frequently Asked Questions (FAQ)

Common questions about Кориол (FAQ)


Q: Does Кориол cause weight gain, and is that a common side effect?

Weight increase is documented in official drug labeling as a side effect. According to clinical trial data, this effect was observed in at least 10% of patients with left ventricular dysfunction following a heart attack.


Q: What happens if I stop taking Кориол suddenly?

Official information explicitly warns against abruptly discontinuing the use of this medicine. Stopping suddenly carries a risk of acute exacerbation, or worsening, of existing coronary artery disease.


Q: Can Кориол affect my energy levels or make me feel tired all the time?

Yes, fatigue and asthenia (unusual weakness or lack of energy) are listed as very common side effects. In some clinical trials, these effects were experienced by 10% or more of patients with heart failure.


Q: How quickly should I expect to see an effect after starting Кориол?

Initial effects, such as lowering heart rate and blood pressure, can begin relatively quickly. However, the official documents describe that a full reduction in blood pressure may take approximately 7 to 14 days following the start of therapy or a dose adjustment.


Q: Can older adults take Кориол safely?

Official prescribing information notes that plasma levels of the medicine may average about 50% higher in older subjects compared to younger subjects. Due to this difference, official guidelines note that dosage may require individual adjustment and close monitoring.


Q: What are the long-term safety considerations for taking Кориол?

The drug is intended for long-term management of chronic cardiovascular conditions. Long-term use is associated with known risks such as low heart rate and low blood pressure. Some regulatory documents note that long-term observational data is not fully established for all health outcomes.


Q: Is the research evidence for Кориол considered strong?

The clinical evidence for the medicine is based on large-scale randomized clinical trials (RCTs). These studies have consistently reported reduced rates of all-cause mortality and hospitalization for the medicine’s main cardiovascular indications, particularly in heart failure.


Q: What should be done if I experience a cold sensation in my hands and feet while on Кориол?

Official documents describe cold extremities (hands and feet) as a possible, but less common, side effect of the medicine. Consultation with a healthcare provider is recommended regarding this symptom.


Q: If I feel better, can I stop taking Кориол?

The medication is typically prescribed for long-term management of chronic conditions, even if you feel better. Official information states the therapy must not be stopped abruptly due to the serious risk of adverse cardiac events.


Q: Why would a doctor choose Кориол instead of a different drug for high blood pressure?

The medicine is classified as a dual-action agent. Its unique action involves both non-selective beta-blocking and alpha-blocking properties, which results in both a reduced heart rate and the widening of blood vessels (vasodilation) to reduce overall peripheral resistance.


Q: Is it safe to drink alcohol while I am taking Кориол?

Official information suggests caution regarding the combination of this medicine and alcohol. Both substances can independently lower blood pressure, and their combination may lead to additive effects that increase the risk of symptoms like dizziness and fainting.


Q: Can Кориол be taken by people with asthma or other breathing problems?

The medicine is formally contraindicated (should not be used) in patients with bronchial asthma or related bronchospastic conditions. For patients with pre-existing breathing issues other than bronchial asthma, official warnings advise that the medicine should be used with caution, if at all.


Q: Is there a certain time of day that is best to take Кориол?

Official guidelines only specify that the tablet must be taken twice daily and with food to reduce the risk of dizziness upon standing. No specific time of day (such as morning or evening) is mandated in the labeling.


Q: Does Кориол interact with common over-the-counter pain relievers?

Regulatory documents do not list every common OTC pain reliever individually. However, the official information notes a need for caution when co-administering this medicine with other agents that may have additive effects on lowering blood pressure or affecting kidney function.


Q: Is it normal to have vivid dreams or sleep disturbances when taking Кориол?

Official labeling lists sleep disorders, which can include nightmares and abnormal thinking, as possible psychiatric side effects. These effects were noted as uncommon in some regulatory documents.


Q: Does Кориол have any known interactions with herbal supplements?

While specific herbal interactions may not be fully listed, official warnings generally advise informing your doctor about all other substances being taken, including vitamins and herbs, as they may have potential unlisted effects.


Q: Is Кориол used only for blood pressure, or does it have other official uses?

The medicine is approved for more than just high blood pressure (hypertension). Official indications also include the management of chronic heart failure and left ventricular dysfunction following a heart attack.


Q: Are there any food or drinks I should avoid when I'm on Кориол?

The official instruction is that the medicine must be taken with food to modulate its absorption. Alcohol is advised against due to potential additive blood pressure lowering effects. There are no other mandated specific food avoidances listed in the core labeling.


Q: Can women who are planning to become pregnant continue taking Кориол?

Official documents indicate that there is insufficient human data to definitively determine the risk of adverse developmental outcomes during pregnancy. Use is generally advised only if the potential benefit is determined to outweigh the potential risk, and monitoring of the newborn may be required.


Q: Is there a risk of developing diabetes while taking Кориол?

Official information warns that in diabetic patients, the medicine may mask symptoms of hypoglycemia (low blood sugar) or worsen existing hyperglycemia (high blood sugar). The need for monitoring blood glucose levels is noted in the official prescribing information for diabetic patients.


Q: Does Кориол interact with medications for thyroid conditions?

Official documents warn that beta-blockers, such as this medicine, may mask some clinical signs of hyperthyroidism, like a fast heart rate. Additionally, abruptly stopping the medicine may worsen existing thyroid issues.


Q: Can Кориол affect my ability to drive or operate machinery?

Official warnings state the medicine can affect alertness or coordination due to potential side effects like dizziness. Driving or operating machinery should be avoided until an individual knows how the medicine affects their alertness and coordination.


Q: How long does Кориол stay in the body after the last dose?

The medicine is eliminated from the body relatively quickly. Official data indicates that the apparent mean terminal elimination half-life generally ranges from 7 to 10 hours following oral administration.


Q: Are there any known issues with taking Кориол and cold/flu remedies?

Cold and flu remedies often contain sympathomimetic agents (such as decongestants). Official warnings advise caution when combining this medicine with agents that may have additive effects on blood pressure or heart rate.


Q: Does Кориол interact with any medications for depression or anxiety?

Yes, official labeling lists potential interactions with strong inhibitors of the CYP2D6 enzyme, which includes certain Selective Serotonin Reuptake Inhibitors (SSRIs) used for depression or anxiety. These inhibitors may increase the blood levels of the active substance.


Q: Is a dry cough a possible side effect of Кориол?

Yes, cough is listed in the official adverse reactions section. In some clinical trials, cough, which may be dry, was reported by approximately 5% to 9% of patients.


Q: Can I take ibuprofen or aspirin while using Кориол?

Regulatory sources advise general caution when combining the medicine with other agents that may have additive effects on blood pressure or heart rate, or which may affect kidney function. Consultation with a healthcare provider regarding the use of specific non-prescription pain relievers is recommended.


Q: Is it possible for Кориол to make my existing low blood pressure worse?

Yes, the official warning states that hypotension (low blood pressure) may occur during treatment. Official documentation notes that in cases of hypotension, a dose adjustment may be required, particularly for those with existing low blood pressure.


Q: Does official information suggest any specific diet changes while taking Кориол?

The official instruction is that the medicine must be taken with food to modulate absorption. There are no other specific, mandated diet changes listed in the core regulatory labeling.


Q: Is there a generic version of Кориол available?

Yes, the active ingredient in Кориол, Carvedilol, is available in generic form. This means that versions of the medicine manufactured by different companies have been approved by regulatory bodies like the FDA.


Q: Can Кориол be taken by people with low heart rate (bradycardia)?

Severe bradycardia (a very slow heart rate) is listed as a formal contraindication, meaning the medicine should not be used in this condition unless certain safeguards, such as a permanent pacemaker, are in place.


Q: What happens if I take Кориол with common indigestion relief medications?

Regulatory sources generally advise caution when combining this medicine with agents that may affect absorption or have additive effects on lowering blood pressure or heart rate. Indigestion remedies may fall into this category.


Q: Are there any warnings about using Кориол before surgery?

A specific warning exists about the risk of developing Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery. It is important for patients to inform their surgical team that they are taking this medicine.


Q: Does the drug label mention any contraindications related to mental health conditions?

While there are no absolute contraindications solely related to mental health conditions, official information lists psychiatric adverse reactions such as depression and confusion as common or uncommon effects of the drug.


Q: Are there any reported differences in how Кориол affects men versus women?

Official regulatory data for the use of the medicine in treating high blood pressure indicates that there were no age or gender-related differences in patient response to the drug in clinical trials.


Q: Is the brand name 'Кориол' used globally, or are there different names?

The active ingredient, Carvedilol, is known by several brand names globally. For example, it is known as 'Coreg' in the United States, in addition to the brand name 'Кориол' used elsewhere.


Q: Can I take Кориол if I have a history of allergic reactions to other medicines?

The medicine is formally contraindicated (should not be used) in patients with a history of a serious hypersensitivity reaction to any component of this medication or to other medications containing carvedilol.


Q: How is the safety of Кориол during long-term use assessed in studies?

Long-term safety is assessed in large, multi-year randomized clinical trials (RCTs). Researchers track critical measures such as all-cause mortality and hospitalizations to determine the overall benefit-risk profile for patients over time.


Q: What is the connection between Кориол and changes in cholesterol levels?

Official documents state that beta-blockers, as a class, may alter serum lipid profiles. Reported changes can include an increase in VLDL and LDL cholesterol and triglycerides, along with a decrease in HDL cholesterol.

How should Кориол be stored and disposed of?

How to Store and Dispose of Carvedilol (Кориол)

The storage and disposal of Carvedilol tablets must follow strict regulatory guidelines to maintain product integrity and safety.

Official Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), and do not store above 30 C (86 F).
Protection Keep the tablets dry and protected from light and moisture.
Container Keep the medication in the container it came in, and keep the container tightly closed.
Child Safety Store all medicine out of the reach and sight of children.

Disposal

Expired or unused Carvedilol must be safely discarded according to local requirements. The product's labeled restrictions forbid allowing it to reach the sewage system or any water course.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Кориол found in:

A-Z Index: